Biopharm Stock Prediction: KERX Developing New Ways to Treat Patients With CKD
This article was written by Blair Goldenberg, a Financial Analyst at I Know First, and enrolled in a Masters of Finance at Colorado State University.
Biopharm Stock Prediction
Summary- Background on Keryx Biopharmaceuticals (KERX)
- KERX Stock Analysis
- KERX Helping Patients Around the US
- I Know First Algorithm Bullish Forecast For KERX